7.91
price down icon9.81%   -0.86
 
loading
Scisparc Ltd stock is traded at $7.91, with a volume of 29,399. It is down -9.81% in the last 24 hours and up +116.12% over the past month. SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
See More
Previous Close:
$8.77
Open:
$8.65
24h Volume:
29,399
Relative Volume:
0.08
Market Cap:
$4.47M
Revenue:
$927.00K
Net Income/Loss:
$-13.21M
P/E Ratio:
-0.0375
EPS:
-210.8843
Net Cash Flow:
$-4.77M
1W Performance:
+18.24%
1M Performance:
+116.12%
6M Performance:
-72.96%
1Y Performance:
+213.89%
1-Day Range:
Value
$7.50
$8.88
1-Week Range:
Value
$6.50
$9.03
52-Week Range:
Value
$2.448
$80.10

Scisparc Ltd Stock (SPRC) Company Profile

Name
Name
Scisparc Ltd
Name
Phone
-
Name
Address
-
Name
Employee
2
Name
Twitter
Name
Next Earnings Date
2026-04-23
Name
Latest SEC Filings
Name
SPRC's Discussions on Twitter

Compare SPRC vs VRTX, REGN, ARGX, ALNY, ONC

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
SPRC icon
SPRC
Scisparc Ltd
7.91 4.47M 927.00K -13.21M -4.77M -210.88
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
423.92 107.83B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
701.42 73.54B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
783.50 48.72B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
296.11 39.51B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
293.86 32.66B 5.36B 287.73M 924.18M 2.5229

Scisparc Ltd Stock (SPRC) Latest News

pulisher
Apr 30, 2026

Neurothera Labs Announces Continuance into Ontario - TheNewswire

Apr 30, 2026
pulisher
Apr 29, 2026

SciSparc Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Apr 29, 2026
pulisher
Apr 29, 2026

SciSparc (NASDAQ: SPRC) 20-F shows widening losses and going concern risk - Stock Titan

Apr 29, 2026
pulisher
Apr 27, 2026

SPRC Stock Price, Quote & Chart | SCISPARC LTD (NASDAQ:SPRC) - ChartMill

Apr 27, 2026
pulisher
Apr 26, 2026

SciSparc stock rallies after AutoMax files motion on pending merger - MSN

Apr 26, 2026
pulisher
Apr 24, 2026

SPRC Technical Analysis | Trend, Signals & Chart Patterns | SCISPARC LTD (NASDAQ:SPRC) - ChartMill

Apr 24, 2026
pulisher
Apr 23, 2026

Neurothera Labs Engages bullVestor for Investor Relations Activities - TheNewswire

Apr 23, 2026
pulisher
Apr 23, 2026

SciSparc receives Nasdaq notice over stockholders’ equity shortfall - MSN

Apr 23, 2026
pulisher
Apr 21, 2026

SPRC Stock Pops On Volatile Run As Traders Circle - timothysykes.com

Apr 21, 2026
pulisher
Apr 21, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Apr 21, 2026
pulisher
Apr 21, 2026

SciSparc (SPRC) Stock Volume Ratio (Slips) 2026-04-20RSI Overbought Stocks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 21, 2026
pulisher
Apr 20, 2026

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Apr 20, 2026
pulisher
Apr 20, 2026

SPRC | SciSparc Ltd. Ordinary Shares Insider Trading - Quiver Quantitative

Apr 20, 2026
pulisher
Apr 17, 2026

Amnon Ben Shay Net Worth (2026) - GuruFocus

Apr 17, 2026
pulisher
Apr 16, 2026

Adi Zuloff Shani Net Worth (2026) - GuruFocus

Apr 16, 2026
pulisher
Apr 16, 2026

Lior Vider Net Worth (2026) - GuruFocus

Apr 16, 2026
pulisher
Apr 13, 2026

Is SciSparc (SPRC) Stock better than industry peers | Price at $3.02, Down 3.95%Open Stock Signal Network - UBND thành phố Hải Phòng

Apr 13, 2026
pulisher
Apr 13, 2026

Block Trades: Can SciSparc Ltd scale operations efficientlyQuarterly Portfolio Summary & Breakout Confirmation Alerts - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 12, 2026

Institution Moves: Can SciSparc Ltd outperform in the next rallyEntry Point & Community Verified Swing Trade Signals - baoquankhu1.vn

Apr 12, 2026
pulisher
Apr 10, 2026

Market Trends: What makes SciSparc Ltd stock attractive todayOptions Play & Safe Entry Point Alerts - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 09, 2026

MACD Signal: Is SciSparc Ltd impacted by rising ratesWeekly Risk Summary & Real-Time Buy Zone Alerts - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 09, 2026

Institution Moves: Is SciSparc Ltd impacted by rising rates2026 Drop Watch & Breakout Confirmation Alerts - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 07, 2026

Buyback Watch: Can SciSparc Ltd outperform in the next rallyWeekly Trade Analysis & Smart Allocation Stock Tips - baoquankhu1.vn

Apr 07, 2026
pulisher
Apr 03, 2026

SPRC Should I Buy - Intellectia AI

Apr 03, 2026
pulisher
Apr 02, 2026

SPRC Stock Analysis: SciSparc Ltd. Ordinary Shares biotech 0.41% dip at 3.66 view - Newser

Apr 02, 2026
pulisher
Mar 27, 2026

SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Mar 27, 2026
pulisher
Mar 25, 2026

Whale Trades: How correlated is SciSparc Ltd to the S P5002026 Macro Impact & Entry Point Confirmation Alerts - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 23, 2026

SciSparc (SPRC) director Dayan Alon reports 3,651-share ownership stake - Stock Titan

Mar 23, 2026
pulisher
Mar 21, 2026

SPRC SEC FilingsScisparc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 21, 2026
pulisher
Mar 18, 2026

SciSparc (SPRC) director discloses shares, options and RSU awards - stocktitan.net

Mar 18, 2026
pulisher
Mar 18, 2026

SciSparc (SPRC) director reports initial share and option holdings - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

SciSparc (SPRC) director Revach Moshe discloses initial share and RSU holdings - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

SciSparc (SPRC) CEO Adler Oz details share, option and RSU holdings - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

SciSparc (SPRC) director Weiss Amitay details equity holdings - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

SciSparc (SPRC) director Vider Lior details shares, options and RSUs - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

SciSparc (SPRC) CTO details 5,528 Ordinary Shares and option holdings on Form 3 - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

SciSparc (SPRC) director reports 3,651-share stake and RSU grants - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

Sentiment Watch: Can SciSparc Ltd stock outperform in a bear marketRecession Risk & Expert Verified Stock Movement Alerts - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 17, 2026

Buyout Rumor: Is SciSparc Ltd impacted by rising ratesMarket Performance Report & Low Drawdown Investment Ideas - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 17, 2026

SciSparc subsidiary files patent for depression treatment By Investing.com - Investing.com India

Mar 17, 2026
pulisher
Mar 16, 2026

[SCHEDULE 13G] SciSparc Ltd. Passive Investment Disclosure (>5%) - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

SciSparc’s NeuroThera-Backed Collaboration Spurs New Depression Therapy Patent Filing - TipRanks

Mar 16, 2026
pulisher
Mar 16, 2026

Eli Zamir reports ≤5% stake in SciSparc (NASDAQ: SPRC) - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

SciSparc (NASDAQ: SPRC) collaboration advances MEAI-PEA depression patent bid - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy - Bitget

Mar 16, 2026
pulisher
Mar 16, 2026

SciSparc subsidiary files patent for depression treatment - Investing.com

Mar 16, 2026
pulisher
Mar 16, 2026

SciSparc Ltd. Reports NeuroThera Labs' Patent Application for Innovative Depression Treatment Combining MEAI and PEA - quiverquant.com

Mar 16, 2026
pulisher
Mar 12, 2026

SciSparc Subsidiary NeuroThera to Take Majority Stake in Quantum Trials Firm CliniQuantum - TipRanks

Mar 12, 2026
pulisher
Mar 12, 2026

SciSparc (Nasdaq: SPRC) unit to acquire 54% of CliniQuantum and lose NeuroThera control - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

SciSparc’s Neurothera Labs announces publication of international patent - TipRanks

Mar 12, 2026
pulisher
Mar 12, 2026

SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease - Bitget

Mar 12, 2026

Scisparc Ltd Stock (SPRC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$27.83
price down icon 2.45%
$49.47
price down icon 1.24%
$97.54
price down icon 5.71%
$133.26
price down icon 2.25%
$139.48
price down icon 3.22%
ONC ONC
$293.86
price down icon 0.48%
Cap:     |  Volume (24h):